Measuring Resting Energy Use in Children With Crohn's Disease and Ulcerative Colitis
Measures how much energy the body uses at rest in children with bowel inflammation.
Plain-language title generated from the registry record
Registry title: Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
Key facts
- Where
- Alessandria, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 17 years old?
Source: NCT07670975, who can take part
Where in Italy
- Pediatric UnitAlessandria, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
- Trial code
- NCT07670975
- Record updated
- 26 June 2026
- Original description
This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.Read full original descriptionShow less
Measurement of Basal Metabolism in Patients With Crohn's Disease and Ulcerative Colitis and Correlation With Disease Activity.
This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.
Inclusion: Pediatric patients aged 6 to 17 years; New diagnosis of inflammatory bowel disease, including Crohn disease or ulcerative colitis, according to ECCO/ESPGHAN criteria; Written informed consent signed by parents or legal guardians.
Exclusion: Intestinal surgery within 6 weeks before the first evaluation; Parenteral or enteral nutrition within 6 weeks before the first evaluation; Eating disorders or other chronic diseases associated with possible malabsorption.